About Bioniqe Healthcare
Bioniqe Healthcare is a fast-growing pharmaceutical manufacturing enterprise operating with advanced WHO-GMP compliant manufacturing facilities located in Baddi, Solan, Kangra Himachal Pradesh. We specialize in comprehensive third-party contract manufacturing, bio-equivalent formulation development, and custom packaging.
Equipped with high-capacity production machinery, automated filling lines, and clean environments, we empower pharmaceutical marketing brands across India with high quality, competitive pricing, and regulatory endorsement.
Why Choose Bioniqe Healthcare
Delivering uncompromised quality, regulatory assurance, and seamless contract manufacturing operations.
WHO-GMP & ISO Compliance
Our state-of-the-art facility in Baddi, Solan, Kangra Himachal Pradesh operates under strict Revised Schedule M and WHO-GMP certifications, ensuring world-class manufacturing standards for every product.
High Scale Production
Equipped with high-speed automated lines capable of producing billions of tablets, capsules, liquids, and injectables per annum to support high-volume commercial runs.
Zero-Defect Quality Control
Comprehensive IPQC checks, advanced testing labs, and rigorous raw material audits ensure complete batch stability, high efficacy, and 100% bio-equivalence.
On-Time Batch Dispatch
Streamlined supply chain logistics and production planning guarantee rapid turnaround times, helping your brand maintain continuous inventory across markets.
Complete Regulatory Support
From DCGI approvals and trademark clearance to COA documents and custom foil design, our regulatory team handles all compliance complexities for you.
Competitive Costing
Transparent pricing models and high manufacturing efficiency allow us to provide premium quality formulations at optimal margin-friendly costs for marketers.
Compliance & Quality Control
Zero-defect quality checks executed across the manufacturing workflow.
API & Raw Material Audit
Testing of Active Pharmaceutical Ingredients (APIs) and excipients prior to batch release.
In-Process Quality Checks
Monitoring tablet thickness, friability, hardness, dissolution, and fill volumes during production.
COA Release
Certificate of Analysis (COA) issued for every batch validating full analytical compliance.
Frequently Asked Questions
Answers to common queries regarding third-party pharmaceutical manufacturing.
- Drug License (DL 20B / 21B or manufacturing license)
- GST Registration Certificate
- Brand Name / Trademark Registration or Non-resemblance Undertaking
- PAN Card & Company Verification Details
- Tablets & Capsules: 30,000 to 50,000 units
- Oral Liquids / Syrups: 2,000 to 3,000 bottles
- Injectables: 1,000 to 3,000 vials/ampoules